Nano-X Imaging Ltd. (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-based bone health product, HealthOST, in Italy.

According to a press release, HealthOST is designed to analyze eligible routine CT scans and provide qualitative and quantitative assessments of the spine to support evaluation of musculoskeletal conditions, including osteoporosis. The product is intended to help clinicians identify patients who may benefit from further evaluation by using imaging studies already conducted for other clinical purposes.

Technologic s.r.l. is the contractual counterparty in the agreement. Its affiliated company, Tecnologie Avanzate, reports a history in the Italian medical technology market dating to 1974.

Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox, said: "This agreement expands the reach of HealthOST, our AI-powered bone solution, into the Italian market and marks another step in our efforts to bring advanced bone health assessment capabilities to healthcare providers worldwide."

Vittorio Catolla Cavalcanti, CEO of Technologic s.r.l., said the collaboration reflects a commitment to providing healthcare professionals with advanced solutions and that the company looks forward to introducing HealthOST to healthcare providers across Italy.

Nano-X Imaging is headquartered in Petach Tikva, Israel, and its Nanox AI subsidiary develops deep-learning medical imaging analytics targeting chronic and acute diseases.